Suzhou Competitors

688137 Stock

35.29 0.78 2.26%

Suzhou Novoprotein competes with Winner Medical Co, Guangzhou Boji, Shannon Semiconductor, CareRay Digital, and BrightGene Bio; as well as few others. The company operates under Biotechnology sector and is part of Health Care industry. Analyzing Suzhou Novoprotein competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Suzhou Novoprotein to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Suzhou Novoprotein Correlation with its peers.

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Suzhou Novoprotein competition on your existing holdings.

Specify up to 10 symbols:

Hype

Prediction

Low	Estimated	High
33.68	35.29	36.90

Details

Intrinsic

Valuation

Low	Real	High
29.71	31.32	38.82

Details

Naive

Forecast

Low	Next	High
33.09	34.70	36.31

Details

Bollinger

Band Projection (param)

Lower	Middle Band	Upper
31.33	34.13	36.93

Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Suzhou Novoprotein. Your research has to be compared to or analyzed against Suzhou Novoprotein's peers to derive any actionable benefits. When done correctly, Suzhou Novoprotein's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Suzhou Novoprotein.

Suzhou Novoprotein Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Suzhou Novoprotein and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Suzhou and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Suzhou Novoprotein does not affect the price movement of the other competitor.

	300888	300404	300475	688607	688166	688981	301370	688261
300888		-0.04	0.2	-0.01	0.36	-0.24	0.03	0.05	300888
300404	-0.04		0.67	0.88	0.61	0.01	0.92	0.76	300404
300475	0.2	0.67		0.77	0.89	0.28	0.51	0.38	300475
688607	-0.01	0.88	0.77		0.74	0.04	0.84	0.69	688607
688166	0.36	0.61	0.89	0.74		-0.07	0.55	0.42	688166
688981	-0.24	0.01	0.28	0.04	-0.07		-0.23	-0.21	688981
301370	0.03	0.92	0.51	0.84	0.55	-0.23		0.89	301370
688261	0.05	0.76	0.38	0.69	0.42	-0.21	0.89		688261
	300888	300404	300475	688607	688166	688981	301370	688261

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

High positive correlations

301370	+ 0.92	300404
688166	+ 0.89	300475
688261	+ 0.89	301370
688607	+ 0.88	300404
301370	+ 0.84	688607
688607	+ 0.77	300475

High negative correlations

688981	- 0.24	300888
301370	- 0.23	688981
688261	- 0.21	688981
688981	- 0.07	688166
300404	- 0.04	300888
688607	- 0.01	300888

Risk-Adjusted Indicators

There is a big difference between Suzhou Stock performing well and Suzhou Novoprotein Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Suzhou Novoprotein's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
300888	2.27	0.35	0.19	(0.65)	2.23	(2.53)	6.53	(3.73)	15.23
300404	2.13	0.16	0.11	(0.41)	2.66	(2.17)	5.77	(4.90)	19.16
300475	2.66	0.69	0.28	1.47	2.32	(3.28)	8.27	(4.53)	19.13
688607	1.58	0.20	0.12	1.69	2.33	(1.50)	2.56	(3.36)	9.48
688166	2.36	0.35	0.26	(0.54)	1.80	(3.30)	7.78	(3.35)	14.71
688981	2.37	0.21	0.10	0.28	2.62	(2.46)	4.81	(4.54)	15.27
301370	1.75	(0.01)	0.06	(0.10)	2.49	(1.71)	3.51	(4.38)	12.73
688261	2.25	(0.04)	0.00	(0.76)	0.00	0.00	4.48	(4.42)	13.29

Cross Equities Net Income Analysis

Compare Suzhou Novoprotein and related stocks such as Winner Medical Co, Guangzhou Boji Medical, and Shannon Semiconductor Net Income Over Time

	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
300888	409.6 M	409.6 M	409.6 M	409.6 M	409.6 M	409.6 M	409.6 M	427.2 M	424.7 M	546.3 M	3.8 B	1.2 B	1.7 B	580.4 M	667.5 M	1.2 B
300404	33.3 M	33.3 M	33.3 M	35.2 M	38 M	25.7 M	2.1 M	(24.5 M)	7.4 M	6.6 M	17 M	38.9 M	27.7 M	24.3 M	21.9 M	15.4 M
300475	73.2 M	73.2 M	96.1 M	112.6 M	158.1 M	105.3 M	96.6 M	87.4 M	33.4 M	64.6 M	64.4 M	223.9 M	313.7 M	377.7 M	434.3 M	456 M
688607	21.6 M	21.6 M	21.6 M	21.6 M	21.6 M	21.6 M	21.6 M	21.6 M	49.3 M	48.2 M	75.1 M	85.1 M	(5.7 M)	15.4 M	13.9 M	13.2 M
688166	17.1 M	17.1 M	17.1 M	17.1 M	17.1 M	17.1 M	17.1 M	45.9 M	73.2 M	111.1 M	169.9 M	244 M	239.6 M	202.5 M	232.8 M	151.7 M
688981	234.7 M	234.7 M	234.7 M	234.7 M	234.7 M	234.7 M	234.7 M	234.7 M	234.7 M	234.7 M	715.5 M	1.7 B	1.8 B	902.5 M	492.7 M	468.1 M
688261	9.1 M	9.1 M	9.1 M	9.1 M	9.1 M	9.1 M	9.1 M	9.1 M	9.1 M	9.1 M	27.7 M	146.9 M	284.4 M	140 M	161 M	133.8 M

Suzhou Novoprotein and related stocks such as Winner Medical Co, Guangzhou Boji Medical, and Shannon Semiconductor Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Suzhou Novoprotein financial statement analysis. It represents the amount of money remaining after all of Suzhou Novoprotein Scientific operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Suzhou Novoprotein Competitive Analysis

The better you understand Suzhou Novoprotein competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Suzhou Novoprotein's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Suzhou Novoprotein's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	688137	300888	300404	300475	688607	688166	688981	301370	688261
	2.26 35.29 Suzhou	7.30 46.76 Winner	2.12 10.13 Guangzhou	9.82 43.28 Shannon	5.29 17.50 CareRay	1.96 43.17 BrightGene	1.97 94.81 Semiconductor	0.93 11.96 GKHT	4.10 45.20 Suzhou
Market Volatility (90 Days Market Risk)	Very steady	Very steady	Somewhat reliable	Not too volatile	Not too volatile	Very steady	Very steady	Somewhat reliable	Very steady
Market Performance (90 Days Performance)	Very Weak	Insignificant	Modest	Good	OK	Good	OK	Very Weak	Very Weak
Odds of Financial Distress (Probability Of Bankruptcy)	Quite High	Low	Low	Very Small	Low	Low	Very Small	Low	Quite High
Current Valuation (Equity Enterprise Value)	Over Valued	Over Valued	Over Valued	Over Valued	Over Valued	Over Valued	Fairly Valued	Over Valued	Over Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available
Trade Advice (90 Days Macroaxis Advice)	Strong Sell	Strong Sell	Strong Sell	Strong Hold	Strong Hold	Strong Sell	Strong Hold	Strong Sell	Strong Sell
Net Asset	2.3 B	17.11 B	1.43 B	4.55 B	947.3 M	5.03 B	49.16 B	N/A	3.01 B
Profit Margin	-0.43	-0.12	0.0592	0.0261	0.0595	0.15	0.0746	0.0226	0.0398
EBITDA	(42.31 M)	766.7 M	36.86 M	940.46 M	22.39 M	225.35 M	3.16 B	281.61 M	37.34 M
Operating Margin	-0.5	0.13	0.0883	0.0381	0.074	-0.14	0.0972	0.0349	0.0494
Current Valuation	1.88 B	24.18 B	3.67 B	21.04 B	1.13 B	19.89 B	475.92 B	6.03 B	3.46 B
Price To Book	1.16	2.4	3.95	6.71	1.81	7.75	5.07	2.3	1.92
Retained Earnings	149.52 M	6.61 B	186.52 M	1.42 B	191.09 M	830.44 M	6.17 B	N/A	417.6 M
Beta	1.95	0.45	0.04	0.94	0.52	0.62	0.16	N/A	0.39
Number Of Employees	N/A	13.01 K	1.09 K	598	N/A	N/A	20.22 K	1.12 K	N/A
Shares Outstanding	70.18 M	582.33 M	383.06 M	457.57 M	88.13 M	422.47 M	1.99 B	470.6 M	122.53 M
Cash Flow From Operations	69.16 M	1.06 B	35.95 M	711.65 M	21.48 M	194.77 M	3.18 B	N/A	70.55 M
Annual Yield	0.0142	0.0192	0.001	0.0038	0.0031	N/A	N/A	0.0099	0.004
Total Debt	11.08 M	1.49 B	29.88 M	443.1 M	8.12 M	156.87 M	3.53 B	N/A	30.02 M
Return On Equity	-0.0254	-0.0755	0.0493	0.18	0.0204	0.0825	0.0225	0.0677	0.0139
Return On Asset	-0.0221	0.0144	0.007	0.0768	0.0119	0.0227	0.0017	0.0221	-2.0E-4
Book Value Per Share	30.57	19.71	2.59	6.46	9.77	5.57	2.59	5.24	23.67
Total Asset	2.3 B	17.11 B	1.43 B	4.55 B	947.3 M	5.03 B	49.16 B	N/A	3.01 B
Target Price	N/A	43.86	11.74	N/A	N/A	44.21	65.12	N/A	35.73
Last Dividend Paid	N/A	0.9	0.01	0.17	N/A	0.096	N/A	0.12	N/A
Shares Owned By Institutions	5.01	3.42	2.41	36.12	3.74	18.1	32.11	15.88	26.39
Market Capitalization	2.48 B	27.23 B	3.88 B	19.8 B	1.54 B	18.24 B	470.38 B	5.63 B	5.54 B
Price To Earnings To Growth	N/A	N/A	N/A	N/A	N/A	N/A	3.57	N/A	N/A
Price To Sales	19.43	3.3	5.15	0.98	5.25	14.22	62.71	0.78	5.52
Net Income	12.84 M	580.4 M	24.34 M	377.66 M	15.41 M	200.58 M	492.75 M	N/A	140.19 M
Earnings Per Share	-0.31	-1.72	0.12	1.16	0.27	0.45	0.44	0.35	0.32
Shares Owned By Insiders	71.27	78.49	44.11	17.3	46.79	39.34	10.05	57.36	36.2
Revenue	153.19 M	8.19 B	555.83 M	11.27 B	273.74 M	1.18 B	8.03 B	7.2 B	972.85 M
Working Capital	2.02 B	6.28 B	457.67 M	1.64 B	716.7 M	917.49 M	6.02 B	N/A	2.62 B
Gross Profit	127.45 M	3.7 B	232.17 M	1.14 B	293.9 M	1.28 B	1.22 B	729.87 M	33.03 M
Day Typical Price	34.92	45.93	10.01	42.19	17.2	42.72	94.31	11.89	44.56
Accumulation Distribution	0.0328	0.1	0.0404	0.0921	0.0592	0.0392	0.0325	0.0217	0.0468
Market Facilitation Index	1.16	4.97	0.41	4.02	1.04	1.7	3.11	0.26	2.12
Daily Balance Of Power	0.6724	0.6398	0.5122	0.9627	0.8462	0.4882	0.5884	0.4231	0.8396
Period Momentum Indicator	0.78	3.18	0.21	3.87	0.88	0.83	1.83	0.11	1.78
Rate Of Daily Change	1.02	1.07	1.02	1.1	1.05	1.02	1.02	1.01	1.04
Day Median Price	34.74	45.52	9.95	41.65	17.05	42.5	94.06	11.86	44.24
Price Action Indicator	0.94	2.83	0.29	3.57	0.89	1.09	1.67	0.16	1.85
Relative Strength Index	56.09	55.78	50.15	59.42	58.31	60.54	45.25	47.42	48.45
Coefficient Of Variation	(6,079)	707.98	1403.02	567.97	1073.26	688.96	1844.28	4352.19	(8,719)
Mean Deviation	1.2	2.27	2.13	2.66	1.58	2.36	2.37	1.75	2.25
Jensen Alpha	(0.05)	0.3531	0.1569	0.6897	0.2024	0.35	0.2121	(0.01)	(0.04)
Total Risk Alpha	0.1629	0.8081	0.606	1.11	0.4591	0.825	0.5262	0.3544	0.3146
Sortino Ratio	N/A	0.1942	0.1077	0.2753	0.1167	0.2629	0.0969	0.059	N/A
Downside Variance	N/A	7.52	8.97	7.45	6.58	4.33	7.26	6.96	N/A
Standard Deviation	1.59	3.07	3.13	3.7	2.15	3.09	2.99	2.46	2.85
Kurtosis	0.3491	0.7968	3.86	2.19	1.83	0.9367	1.27	1.86	(0.13)
Potential Upside	3.05	6.53	5.77	8.27	2.56	7.78	4.81	3.51	4.48
Treynor Ratio	0.2526	(0.65)	(0.41)	1.47	1.69	(0.54)	0.2759	(0.1)	(0.76)
Maximum Drawdown	6.58	15.23	19.16	19.13	9.48	14.71	15.27	12.73	13.29
Variance	2.53	9.42	9.82	13.72	4.61	9.54	8.93	6.04	8.14
Market Risk Adjusted Performance	0.2626	(0.64)	(0.40)	1.48	1.7	(0.53)	0.2859	(0.09)	(0.75)
Risk Adjusted Performance	(0.01)	0.1301	0.0693	0.1609	0.0871	0.1336	0.0543	0.0265	(0)
Skewness	0.2695	0.4349	1.02	1.13	(0.65)	0.9975	0.7731	0.2895	(0.12)
Semi Deviation	N/A	2.23	2.66	2.32	2.33	1.8	2.62	2.49	N/A
Information Ratio	0.0459	0.1735	0.1029	0.2028	0.1393	0.1772	0.0874	0.0633	0.0232
Value At Risk	(2.33)	(3.73)	(4.90)	(4.53)	(3.36)	(3.35)	(4.54)	(4.38)	(4.42)
Expected Short fall	N/A	(2.53)	(2.17)	(3.28)	(1.50)	(3.30)	(2.46)	(1.71)	N/A
Downside Deviation	N/A	2.74	2.99	2.73	2.56	2.08	2.69	2.64	N/A
Semi Variance	N/A	4.97	7.06	5.4	5.43	3.24	6.86	6.2	N/A

Suzhou Novoprotein Competition Performance Charts

Five steps to successful analysis of Suzhou Novoprotein Competition

Suzhou Novoprotein's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Suzhou Novoprotein in relation to its competition. Suzhou Novoprotein's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of Suzhou Novoprotein in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Suzhou Novoprotein's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Suzhou Novoprotein, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Suzhou Novoprotein position

In addition to having Suzhou Novoprotein in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Social Domain Thematic Idea Now

Social Domain

New or established large and mid-sized companies that are involved in the social media industry, including entities that provide web-based or mobile media applications and services across across large segment of population in multiple geographical areas. The Social Domain theme has 24 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Social Domain Theme or any other thematic opportunities.

View All Next

Launch

Other Information on Investing in Suzhou Stock

Suzhou Novoprotein financial ratios help investors to determine whether Suzhou Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Suzhou with respect to the benefits of owning Suzhou Novoprotein security.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Suzhou Competitors

Specify up to 10 symbols:

Suzhou Novoprotein Competition Correlation Matrix

Risk-Adjusted Indicators

Cross Equities Net Income Analysis

Suzhou Novoprotein and related stocks such as Winner Medical Co, Guangzhou Boji Medical, and Shannon Semiconductor Net Income description

Suzhou Novoprotein Competitive Analysis

Suzhou Novoprotein Competition Performance Charts

Five steps to successful analysis of Suzhou Novoprotein Competition

Complement your Suzhou Novoprotein position

Did You Try This Idea?

Run Social Domain Thematic Idea Now

Social Domain

Other Information on Investing in Suzhou Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY